Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TYMP | P19971 | 6/20 | 0.40 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.31 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31657632 | 0.91 | TYMP (0.40) | KDM4ETYMPTAS1R3TAS1R1 | |
| SCHEMBL30091735 | 0.91 | TYMP (0.40) | KDM4ETYMPTAS1R3TAS1R1 | |
| SCHEMBL30396329 | 0.80 | TYMP (0.51) | KDM4ETYMPTAS1R3TAS1R1 | |
| SCHEMBL23425410 | 0.80 | KDM4E (0.46) | KDM4ETYMPTAS1R3TAS1R1 | |
| SCHEMBL25307592 | 0.80 | TYMP (0.45) | KDM4ETYMPTAS1R3TAS1R1 | |
| SCHEMBL24166806 | 0.80 | TYMP (0.45) | KDM4ETYMPTAS1R3TAS1R1 | |
| SCHEMBL22401412 | 0.80 | TYMP (0.45) | KDM4ETYMPTAS1R3TAS1R1 | |
| SCHEMBL23456230 | 0.80 | TYMP (0.45) | KDM4ETYMPTAS1R3TAS1R1 | |
| SCHEMBL1598576 | 0.80 | TYMP (0.45) | KDM4ETYMPTAS1R3TAS1R1 | |
| SCHEMBL7197818 | 0.79 | KDM4E (0.48) | KDM4ETYMPTAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4419536-A1 | OLIGONUCLEOTIDES WITH 2'-DEOXY-2'-F-2'-C-METHYL NUCLEOTIDES | Alnylam Pharmaceuticals, Inc. (US) | 2024-08-28 | — | — | EP | disclosed |
| WO-2023069495-A1 | OLIGONUCLEOTIDES WITH 2'-DEOXY-2'-F-2'-C-METHYL NUCLEOTIDES | ALNYLAM PHARMACEUTICALS, INC. (US) | 2023-04-27 | — | — | WO | disclosed |